Furthermore, USP30-AS1 interacts with ANKRD13A to disrupt HLA-I protein trafficking from membrane to cytoplasm, potentially enabling immune evasion by reducing tumor antigen presentation. The gene discussed is USP30; the disease is neoplasm.